Ultrahaptics Develops Unique Technology that Uses Ultrasound to Create Tactile Sensations in Mid-Air

A leading developer of technology that uses ultrasound to create tactile sensations in mid-air has been awarded £10.1 million to grow its business globally.

A touchless button being used to operate a laptop. Image Credit: Ultrahaptics

The new investment, led by Woodford Investment Management, will allow Bristol-based Ultrahaptics to work with manufacturers in different markets as well as reaching new markets and customers.

Ultrahaptics, a spin-out company based on research developed at the University of Bristol by PhD student Tom Carter, has developed a unique technology that brings back the sense of touch to touchless interfaces by feeling without touching.

The system uses ultrasound to project sensations through the air and directly onto the user, revolutionising how people interact with computers, automobiles and consumer goods. Users can feel touchless buttons, get feedback for mid-air gestures or interact with virtual objects.

The start-up company’s ultrasonic haptic technology is being licensed into various markets including consumer electronics, household appliances and the car industry. The company already has several leading businesses enrolled onto its evaluation programme.

Steve Cliffe, CEO of Ultrahaptics, said: "The company is engaged with Tier 1 manufacturers in multiple markets and the investment from Woodford Investment Management will allow us to fulfil this demand and address additional markets and customers. Our technology completes gesture control by re-introducing the sense of touch."

The company's early commercialisation efforts were supported by the University's Research and Enterprise Development team and funded from the University's EPSRC Impact Acceleration Account.

Ultrahaptics joined the Bristol SETsquared Centre - the University's award-winning business incubator - hot on the heels of winning the University's New Enterprise Competition two years ago.

SETsquared in now based in Engine Shed and Ultrahaptics has gone from strength to strength, expanding from one desk to 24 and occupying the biggest office.

Invest Bristol and Bath have supported Ultrahaptics in finding the right office space in the Enterprise Zone for next year, ensuring they stay in the region.

Nick Sturge, Director of the Bristol SETsquared Centre, said: "Ultrahaptics joined the Bristol SETsquared Centre in November 2013 and has grown rapidly in the centre, here in Engine Shed, to a team of over 20 people. We are hugely excited to be working with them and being a part of their journey.

"This could be one of the most exciting stars coming out of the Bristol and Bath ecosystem and we look forward to the ride. Their success reflects the ambition in the city-region and the complimentary activities of the University of Bristol, SETsquared and Invest Bristol & Bath, who are helping them with their growth plans in the city."

Mark Reilly of existing shareholder IP Group plc (LSE:IPO) added: "We have been involved with Ultrahaptics from the very beginning and have been delighted with both the technical and commercial progress achieved to date. We are extremely excited to participate in this Series A funding and the company’s continued development."

Source: http://www.bristol.ac.uk/

Tell Us What You Think

Do you have a review, update or anything you would like to add to this news story?

Leave your feedback
Your comment type
Submit
Azthena logo

AZoM.com powered by Azthena AI

Your AI Assistant finding answers from trusted AZoM content

Your AI Powered Scientific Assistant

Hi, I'm Azthena, you can trust me to find commercial scientific answers from AZoNetwork.com.

A few things you need to know before we start. Please read and accept to continue.

  • Use of “Azthena” is subject to the terms and conditions of use as set out by OpenAI.
  • Content provided on any AZoNetwork sites are subject to the site Terms & Conditions and Privacy Policy.
  • Large Language Models can make mistakes. Consider checking important information.

Great. Ask your question.

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.